Clinical trials - Press Releases

Date	Title	Company
04-Jun-2021	Achilles Therapeutics Details Phase I/IIa Clinical Trial Design of CHIRON in Patients with Advanced Non-Small Cell Lung Cancer at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting	Achilles Therapeutics
04-Jun-2021	iTeos Therapeutics Announces New Phase 1/2a Data Indicating Antitumor Activity of inupadenant, its Adenosine A2A Receptor Antagonist, at ASCO 2021	iTeos Therapeutics
04-Jun-2021	LINK Medical and Insife partnership combines full CRO services with powerful safety and pharmacovigilance tools	LINK Medical
04-Jun-2021	Sleep Apnea Devices Industry – Global Revenue Growth Predictions	MarketsandMarkets Research Private Ltd.
04-Jun-2021	Healthcare IT Market - Global Industry is Expecting a Major Makeover in Near Future	MarketsandMarkets Research Private Ltd.
04-Jun-2021	API Market – This is How Pandemic Has Affected the Global API Manufacturing	MarketsandMarkets Research Private Ltd.
04-Jun-2021	Emerging Trends to Boost Global Revenue for the Medical Equipment Maintenance Market	MarketsandMarkets Research Private Ltd.
04-Jun-2021	Novartis continues to push the boundaries of innovation, reimagining medicine, with bold science as it today unveils strong presence at ASCO, including overall survival data in prostate and breast cancer	Novartis
04-Jun-2021	Immutep reports positive final data from the INSIGHT-004 phase I study of LAG-3 therapy, Efti, at ASCO 2021	Immutep Limited
04-Jun-2021	Immutep Reports Positive Data from its TACTI-002 Phase II Study of LAG-3 Therapy, Efti, at ASCO 2021	Immutep
04-Jun-2021	Lynparza reduced the risk of cancer recurrence by 42% in the adjuvant treatment of patients with germline BRCA-mutated high-risk early breast cancer in OlympiA Phase III trial	AstraZeneca
04-Jun-2021	Imfinzi demonstrated unprecedented survival in unresectable, Stage III lung cancer with 43% of patients surviving five years	AstraZeneca
04-Jun-2021	New Phase 3b Psoriatic Arthritis (PsA) Data Show TREMFYA® ▼ (guselkumab) Achieved Sustained Improvement in Joint Symptoms and Rate of Complete Skin Clearance in Patients with Inadequate Response to Tumour Necrosis Factor Inhibition (TNFi-IR)	Janssen
04-Jun-2021	Ostomy Care Market Worth USD 3.5 Billion – A Surge in Cancer Cases to Fuel Market Growth	MarketsandMarkets Research Private Ltd.
04-Jun-2021	Avance Clinical's USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities	Avance Clinical
03-Jun-2021	Eli Lilly’s tirzepatide continues to outperform popular diabetes drugs in head-to-head clinical trials, says GlobalData	Eli Lilly
03-Jun-2021	First patient dosed in QBiotics & MSD clinical trial collaboration for unresectable melanoma	QBiotics & MSD
02-Jun-2021	Cmed Technology adds more capabilities to its encapsia platform and reports increased demand for use in decentralized trials	Cmed Technology
02-Jun-2021	Biogen and Bio-Thera Announce Positive Results From Phase 3 Study of BAT1806, a Proposed Biosimilar Referencing Actemra® (Tocilizumab)	Biogen and Bio-Thera
02-Jun-2021	Companion Diagnostics Market to Reach USD 6.8 billion by 2025 – Growing Significance in Drug Development	MarketsandMarkets Research Private Ltd.